Epirus Biopharmaceuticals' IPO

Epirus Biopharmaceuticals raised a round of funding on November 20, 2005. Investors include Public.

Epirus is building a global biosimilar enterprise to improve patient access to important medicines. The Company's strategy for commercial success relies on targeted approaches for diverse global mark…

Articles about Epirus Biopharmaceuticals' IPO: